Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

NCT01297400 is registered in ClinicalTrials.gov with Skingenix, Inc. as lead sponsor.

NCT NCT01297400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01297400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Lead sponsor
Skingenix, Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
March 11, 2022
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

burns